Q3 2020 Torrent Pharmaceuticals Ltd Earnings Call Transcript
Ladies and gentlemen, good day, and welcome to Torrent Pharmaceuticals Limited Q3 FY '20 Earnings Conference Call. We have with us on the call today, Mr. Sanjay Gupta, Executive Director, International Business; Mr. Sudhir Menon, Chief Financial Officer; and Mr. Aman Mehta, Chief Marketing Officer, India Business. (Operator Instructions) Please note that this conference is being recorded. I now hand conference over to Mr. Sanjay Gupta. Thank you, and over to you, sir.
Thank you, Stanton. Good evening, everyone, and welcome to our Q3 FY '20 earnings call. I will take you through some of our key financial highlights of Q3 and make some comments on our key markets. .
Q3 revenues were INR 1,966 crore, down by 4% on a year-on-year basis. Q3 revenues of previous year, including -- included onetime patent-related settlement income. Adjusted for this, Q3 revenue is down by 1%. EBITDA was at INR 591 crore, up by 6% on a year-on-year basis. Again, adjusted for onetime
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
